JNCI cancer spectrum Journal

Overview
Identity
View All

publication venue for

Hearing/vestibular problems, racial differences, and associations with physical function impairment among breast cancer survivors.. 10. 2026
Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors.. 10. 2026
Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up.. 10. 2026
Diet, nutrition, and hormone therapy for prostate cancer: a systematic review with implications for future interventions.. 10. 2026
Longitudinal assessment of cognitive function in patients with breast cancer and lymphoma receiving chemotherapy.. 9. 2025
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer study.. 8. 2024
Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network.. 8. 2024
Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma.. 7. 2023
Association of metformin, aspirin, and cancer incidence with mortality risk in adults with diabetes.. 7. 2023
Access to High-Volume Hospitals for High-Risk Cancer Surgery for Racial and Ethnic Minoritized Groups.. 6. 2022
Pitfall in the Design and Analysis of Comparative Oncology Trials With a Time-to-Event Endpoint and Recommendations.. 6. 2022
Association of Daily Alcohol Intake, Volumetric Breast Density, and Breast Cancer Risk.. 5. 2021
APOE. 5. 2021
Breast Cancer Mortality Hot Spots Among Black Women With de Novo Metastatic Breast Cancer.. 5. 2020
Response to Meurs, Menke-Pluijmers, Seisling, and Westenend.. 4:-. 2020
Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes.. 3:-. 2019
Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma.. 3:-. 2019